Skip to search formSkip to main contentSkip to account menu

AR-13324

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Benzoatesbeta-Alanine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Evaluation of the Potential of AR-13324 and AR-13503 to Induce Phospholipidosis
2016
2016
The mechanisms of increasing outflow facility by AR-13324M in human eyes
2016
2016
A kind of AR-13324 preparation method
  • 李钰
  • 2016
  • Corpus ID: 217510680
The present invention relates to a kind of AR 13324 preparation method, the present invention utilizes chiral ligand chiral… 
2016
2016
Two Phase 3 studies of the efficacy and safety of AR-13324 Ophthalmic Solution 0.02%: in Patients with Open Angle Glaucoma and Ocular Hypertension
2016
2016
Real-time Visualization of AR-13324 Effects on Schlemm’s Canal and Scleral Vessels in Living Mice
Methods: Two strains of young mice (C57 and CD1, 2-5 months old) were given AR-13324 or placebo topically. Schlemm’s Canal (SC… 
2015
2015
Fixed dose combination of AR-13324 and latanoprost (PG324): A double-masked, randomized, controlled study in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).
■ For the primary efficacy variable of mean diurnal IOP at Day 29, PG324 0.02% met the criterion for statistical superiority… 
Highly Cited
2014
Highly Cited
2014
Emerging trabecular outflow drugs.
Glaucoma is a progressive optic neuropathy that is a leading cause of irreversible blindness worldwide.1 Elevated intraocular… 
2013
2013
Evaluation of AR-13324, a novel dual mechanism agent, in lowering of IOP in glaucoma and ocular hypertension
2012
2012
IOP-lowering Efficacy And Tolerability Of AR-13324, A Dual Mechanism Kinase Inhibitor For The Treatment Of Glaucoma
Ser/Thr Kinase Assays. Compounds were screened against human ROCK1 and ROCK2. Additional kinases were selected based upon the… 
2012
2012
Effect of 0.04% AR-13324 on Aqueous Humor Dynamics in Normotensive Monkey Eyes
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)